Editors’ Picks: November Highlights from the AACR Journals
With Thanksgiving behind us here in the United States, the holiday season is in full swing. So, grab some...
AACR Editors Share Latest Selection of Journal Articles
As we keep an eye out for those promised May flowers, we bring you the latest round of Editors’...
April Editors’ Picks from AACR Journals
As April comes to a close, it’s time to look back at some of the exciting research published in the...
May Highlights from AACR Journals
This month’s selection of studies picked by the editors of the AACR journals includes a new bispecific antibody for...
Editors’ Picks: October Highlights from AACR Journals
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
AACR Annual Meeting 2023: The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
Detecting Cancer with Body Fluids Other Than Blood
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
AACR Journals to Share Editors’ Picks
The American Association for Cancer Research (AACR) publishes eight esteemed scientific journals. Each month, these journals feature a wide...
Ductal Carcinoma In Situ: The Weight of the Word “Cancer”
What is cancer, exactly? For the most part, experts agree. The National Cancer Institute defines cancer as “a disease...
SABCS 2016: Extended Letrozole Therapy May Have Limited Benefits
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...
Editors’ Picks: June Highlights From the AACR Journals
As we head into summer, enjoy this month’s selection of studies spotlighted by the editors of the 10 AACR...
FDA Approvals in Oncology: January-March 2023
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
Editors’ Picks: January Highlights from AACR Journals
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
AACR Annual Meeting 2019: Past, Present, and Future of CDK4/6-targeted Therapeutics
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...
December Editors’ Picks from AACR Journals
As the year winds down, here’s our final edition of Editors’ Picks for 2019. This regular feature highlights one...
From the Journals: Editors’ Picks for November
Each month, the editors from the portfolio of scientific journals published by the American Association for Cancer Research (AACR)...
Rethinking DCIS: A Conversation with Dr. Kornelia Polyak
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
From the Journals: Editors’ Picks
As a regular feature on this blog, we spotlight 10 “must read” articles selected by our editors from each...
Editors Share Highlights From the AACR Journals
Each month, the editors of the nine AACR journals select one article from each issue to highlight. The featured articles for September described the preclinical evaluation...
Structural Racism and Cancer Disparities: Looking at All the Angles
Melissa Davis, PhD, is putting health disparities under a lens. One that can take an aerial view of the...
Wrapping Up SABCS 2023
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
Editors’ Picks: March Highlights from AACR Journals
As we spring into a new month, it is once again time for our monthly staple of Editors’ Picks. For...
Cancer Survival: Improving Health After Treatment
At long last, cancer survival statistics are beginning to reveal real progress. From 1991 to 2015, the cancer death...
Recent Studies Tap Into AACR Project GENIE Registry
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
AACR Virtual Annual Meeting II: Why Are Cancer Rates Increasing Among Young Adults?
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
July Editors’ Picks from AACR Journals
As a monthly staple on this blog, we feature the editors’ picks from the 10 journal issues published by...
SABCS 2015: Denosumab Improves Outcomes for Patients Taking Aromatase Inhibitors
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
Annual Meeting 2022: How do Tumors Evolve to Resist Therapy?
The story is familiar: A patient is diagnosed with cancer, they begin treatment, and, after a few months, they...
25 Years of Trastuzumab: A Legacy of Innovation
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
Editors’ Picks: June Highlights from the AACR Journals
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...